The Price of Pills episode artwork

EPISODE · Sep 22, 2018 · 26 MIN

The Price of Pills

from In the Balance · host BBC World Service

Drug firms are coming under fire from the US, Europe and China over the cost of some of their products. But is it simply the price we have to pay if we want Big Pharma to keep producing life-saving medicines?President Trump has vowed to drive down drug prices "substantially" - we hear why a lack of haggling means the latest patented pills typically cost more in the US than almost anywhere else in the world.We hear from Big Pharma itself - an industry figure tells us high prices reflect the years of research and development that go into new drugs and that, in time, competition does make them cheaper.Plus, does size matter when brokering better deals with the pharmaceutical firms, and in lower income countries what are the other factors pushing up prices?Contributors: Patricia Danzon, professor of health care management at The Wharton School, University of Pennsylvania; Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations; and Kalipso Chalkidou, director of global health policy at the Center for Global Development.(Picture: Pills on a US dollar bill. Credit: Getty Images)

Episode metadata supplied by the publisher feed · Published Sep 22, 2018

Embed this episode

NOW PLAYING

The Price of Pills

0:00 26:29

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of In the Balance?

This episode is 26 minutes long.

When was this In the Balance episode published?

This episode was published on September 22, 2018.

Can I download this In the Balance episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!